Literature DB >> 6616314

Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis.

D W Dempster, M A Arlot, P J Meunier.   

Abstract

We have compared the mean wall thickness (MWT) and active formation periods (sigma f(A] of trabecular bone packets in iliac crest biopsies from 20 patients (7 male, 13 female) with corticosteroid-induced osteoporosis (CS-OP) and 20 age- and sex-matched controls. The trabecular bone volume (TBV) of the CS-OP patients (9.6% +/- 2.2% [SD]) was significantly reduced compared to controls (19.3% +/- 5.1%). The MWT of CS-OP patients (32.7 +/- 4.3 micron) was also significantly lower than the control value (48.0 +/- 6.2 micron). There was a positive correlation between MWT and TBV in both groups. The mineralization rate (M) of the CS-OP patients (0.54 +/- 0.25 micron/day) was within the normal range, and since there was no increase in osteoid seam thickness, so therefore was the osteoblastic appositional rate (OAR). The active formation period of trabecular bone packets (sigma f(A) = MWT/M) was significantly lower in the CS-OP patients (55.9 +/- 14.4 days) than in the control group (68.1 +/- 9.4 days). MWT and sigma f(A) both decreased with age in the control group, whereas in the CS-OP group they were independent of age. We conclude that corticosteroid therapy results in a reduction of the MWT of trabecular bone packets and, consequently, of TBV. In these patients, where the OAR was normal, the reduction in MWT was apparently caused by a shortening of the life-span of the active osteoblastic population at the basic multicellular unit (BMU) level.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6616314     DOI: 10.1007/bf02405069

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  12 in total

1.  Human osteoclastic activity: qualitative histological measurement.

Authors:  H M FROST; A R VILLANUEVA
Journal:  Henry Ford Hosp Med Bull       Date:  1962-03

2.  Corticosteroid osteoporosis.

Authors:  J C Gallagher; J Aaron; A Horsman; R Wilkinson; B E Nordin
Journal:  Clin Endocrinol Metab       Date:  1973-07

3.  Effect of cortisone treatment on the active transport of calcium by the small intestine.

Authors:  D V Kimberg; R D Baerg; E Gershon; R T Graudusius
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

Review 4.  Tetracycline-based histological analysis of bone remodeling.

Authors:  H M Frost
Journal:  Calcif Tissue Res       Date:  1969

Review 5.  Osteopenia in patients with rheumatic diseases: principles of diagnosis and therapy.

Authors:  T J Hahn; B H Hahn
Journal:  Semin Arthritis Rheum       Date:  1976-11       Impact factor: 5.532

6.  Treatment of osteoporosis with fluoride, calcium, and vitamin D.

Authors:  D Briancon; P J Meunier
Journal:  Orthop Clin North Am       Date:  1981-07       Impact factor: 2.472

7.  Mean wall thickness of trabecular bone packets in the human iliac crest: changes with age.

Authors:  P Lips; P Courpron; P J Meunier
Journal:  Calcif Tissue Res       Date:  1978-11-10

8.  Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration.

Authors:  T J Hahn; L R Halstead; S L Teitelbaum; B H Hahn
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

9.  Tetracycline double-labeling of iliac trabecular bone in 41 normal adults.

Authors:  F Melsen; L Mosekilde
Journal:  Calcif Tissue Res       Date:  1978-12-08

10.  Calcium and phosphorus homeostasis in man. Effect of corticosteroids.

Authors:  B P Lukert; J S Adams
Journal:  Arch Intern Med       Date:  1976-11
View more
  42 in total

Review 1.  Glucocorticoid-induced osteoporosis.

Authors:  R S Weinstein
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

Review 2.  Genetic approaches to determine the role of glucocorticoid signaling in osteoblasts.

Authors:  John R Harrison; Henning W Woitge; Barbara E Kream
Journal:  Endocrine       Date:  2002-02       Impact factor: 3.633

3.  The role of glucocorticoids and prostaglandin E2 in the recruitment of bone marrow mesenchymal cells to the osteoblastic lineage: positive and negative effects.

Authors:  A Scutt; P Bertram; M Bräutigam
Journal:  Calcif Tissue Int       Date:  1996-09       Impact factor: 4.333

4.  Bone microarchitecture in males with corticosteroid-induced osteoporosis.

Authors:  D Chappard; N Josselin; C Rougé-Maillart; E Legrand; M F Baslé; M Audran
Journal:  Osteoporos Int       Date:  2006-11-22       Impact factor: 4.507

5.  Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science.

Authors:  J Compston; D M Reid; J Boisdron; M-L Brandi; N Burlet; D Cahall; P D Delmas; W Dere; J-P Devogelaer; L A Fitzpatrick; B Flamion; N Goel; S Korte; A Laslop; B Mitlak; S Ormarsdottir; J Ringe; R Rizzoli; Y Tsouderos; T Van Staa; J-Y Reginster
Journal:  Osteoporos Int       Date:  2008-07-05       Impact factor: 4.507

6.  Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients.

Authors:  L Montemurro; G Schiraldi; P Fraioli; G Tosi; A Riboldi; G Rizzato
Journal:  Calcif Tissue Int       Date:  1991-08       Impact factor: 4.333

7.  Use of quantitative ultrasound of the hand phalanges in the diagnosis of two different osteoporotic syndromes: Cushing's syndrome and postmenopausal osteoporosis.

Authors:  V Camozzi; V Carraro; M Zangari; F Fallo; F Mantero; G Luisetto
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

8.  Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats.

Authors:  L Dalle Carbonare; F Bertoldo; M T Valenti; S Zordan; S Sella; A Fassina; G Turco; G Realdi; V Lo Cascio; S Giannini
Journal:  J Endocrinol Invest       Date:  2007-10       Impact factor: 4.256

9.  Bone loss after cardiac transplantation: effects of calcium, calcidiol and monofluorophosphate.

Authors:  E Meys; F Terreaux-Duvert; T Beaume-Six; G Dureau; P J Meunier
Journal:  Osteoporos Int       Date:  1993-12       Impact factor: 4.507

10.  Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.

Authors:  K Olgaard; T Storm; N van Wowern; H Daugaard; M Egfjord; E Lewin; L Brandi
Journal:  Calcif Tissue Int       Date:  1992-06       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.